Author | dc.contributor.author | Sorsa, Timo | |
Author | dc.contributor.author | Tervahartiala, Taina | es_CL |
Author | dc.contributor.author | Leppilahti, Jussi | es_CL |
Author | dc.contributor.author | Hernández Ríos, Emma | es_CL |
Author | dc.contributor.author | Gamonal Aravena, Jorge Antonio | es_CL |
Author | dc.contributor.author | Tuomainen, Anita M. | es_CL |
Author | dc.contributor.author | Lauhio, Anneli | es_CL |
Author | dc.contributor.author | Pussinen, Pirkko J. | es_CL |
Author | dc.contributor.author | Mäntylä, Päivi | es_CL |
Admission date | dc.date.accessioned | 2011-09-06T18:12:10Z | |
Available date | dc.date.available | 2011-09-06T18:12:10Z | |
Publication date | dc.date.issued | 2011-02 | |
Cita de ítem | dc.identifier.citation | Pharmacological Research 2011:63(2)108–113 | es_CL |
Identifier | dc.identifier.issn | 1043-6618 | |
Identifier | dc.identifier.other | doi:10.1016/j.phrs.2010.10.005 | |
Identifier | dc.identifier.uri | https://repositorio.uchile.cl/handle/2250/123405 | |
Abstract | dc.description.abstract | Neutrophil collagenase or collagenase-2 (matrix metalloproteinase [MMP]-8) belongs to the collagenase
subgroup of the MMP superfamily of calcium- and zinc-dependent neutral proteinases. MMP-8 is catalytically
the most competent proteinase to initiate type I collagen and extracellular matrix degradation
associated with periodontal and peri-implant tissue destruction leading to tooth and dental implant loss.
Regarding cardiovascular diseases, pathologically excessive MMP-8 has been implicated in atherosclerotic
plaque destabilization and rupture probably through its proteolytic ability to thin the protecting
collagenous fibrous cap lining coronary and other arteries. During the initiation and course of inflammatory
responses in periodontitis, peri-implantitis and cardiovascular diseases, proinflammatory mediators
including especially MMP-8 are up-regulated not only in affected tissues but also in the secreted, diseaseaffected,
oral fluids (gingival crevicular fluid [GCF], peri-implant sulcular fluid [PISF], mouthrinse and
saliva) as well as in serum and plasma. Regarding periodontitis, peri-implantitis and cardiovascular diseases,
the oral fluid and serum MMP-8 analysis has proven to be a sensitive and an objective biomarker
as an indicator of health, pathologic processes and pharmacologic response to therapeutic intervention
including doxycycline medication as an MMP inhibitor. Oral fluids, i.e., GCF, PISF, mouthrinse and saliva
are easily and non-invasively collected for the site- and patient-specific diagnostic analysis in periodontitis
and peri-implantitis, whereas serum and/or plasma sample collection is required for diagnosis and
monitoring of cardiovascular diseases. Research in periodontology and cardiology has identified a need
for the development of innovative point-of-care diagnostic tests for MMP-8. We summarize and review
the recent studies on these topics. | es_CL |
Patrocinador | dc.description.sponsorship | Academy
of Finland, The Sigrid Juselius Foundation, the Antti Wihuri Foundation,
the Helsinki University Central Hospital Research Foundation,
the Finnish Dental Society Apollonia, the D106/05-2-grant from
the University of Chile and the Fondecyt Foundation of Chile. | es_CL |
Lenguage | dc.language.iso | en | es_CL |
Publisher | dc.publisher | Elsevier | es_CL |
Keywords | dc.subject | MMP-8 | es_CL |
Título | dc.title | Collagenase-2 (MMP-8) as a point-of-care biomarker in periodontitis and cardiovascular diseases. Therapeutic response to non-antimicrobial properties of tetracyclines | es_CL |
Document type | dc.type | Artículo de revista | |